$NAKD after browsing through this document, I'm not sure I see much benefit to shareholders. Please, feel free to point out the opposite. But they are saying a r/s WILL happen, between 10:1 and 20:1, they're saying the Independent Expert judges it as not fair but reasonable, says it's unclear whether the market cap is more than NBG (bye-bye $50bn independent expert valuation), says all their business is thus far in China, says they haven't been profitable yet....and more. The advantages they list seem to be limited to: -the potential of the ECV market -no better option This is my first time I've read a document like this, so please, point out anything I'm missing that is a benefit to shareholders. s3.amazonaws.com/content.st...
2
1
2
2 Likes